Share
Journal Information
Issue
Vol. 62. Issue 5.Pages 207-254 (May 2015)
Editorial
Diagnostic criteria for gestational diabetes: The debate goes on
Alejandra Durán Rodriguez-Hervada, Alfonso L. Calle Pascual
Endocrinol Nutr. 2015;62:207-9
Full text access
Original articles
Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia
Carmen Quirós, Ioana Patrascioiu, Mireia Mora, Gloria Beatriz Aranda, Felicia Alexandra Hanzu, Esther Gómez-Gil, Teresa Godás, Irene Halperin
Endocrinol Nutr. 2015;62:210-6
Full text access
Assessment of the outcomes of the treatment of Cushing's disease in the hospitals of Castilla-La Mancha
Isabel Huguet, Miguel Aguirre, Almudena Vicente, Mubarak Alramadan, Iván Quiroga, Julia Silva, Cristina Lamas
Endocrinol Nutr. 2015;62:217-23
Full text access
Kennedy's disease and partial androgen insensitivity syndrome. Report of 4 cases and literature review
Rocío Valera Yepes, Maria Virgili Casas, Monica Povedano Panades, Mireia Guerrero Gual, Carles Villabona Artero
Endocrinol Nutr. 2015;62:224-30
Full text access
Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus
Alfonso Soto González, Niurka Quintela Fernández, Alfonso Pumar López, Ricardo Darias Garzón, Margarita Rivas Fernández, Gloria Barberá Comes
Endocrinol Nutr. 2015;62:233-9
Full text access
Evolution of glycated haemoglobin in adults on growth hormone replacement therapy
Paola Andrea Parra R., Beatriz Barquiel A., Alberto Fernández M., Laura Pérez F., Beatriz Lecumberri S., Mary Gaby Llaro C., Cristina Álvarez-Escolá
Endocrinol Nutr. 2015;62:240-5
Full text access
Review article
Impact of maternal overnutrition on the periconceptional period
Miguel Abraham Velázquez
Endocrinol Nutr. 2015;62:246-53
Full text access
Special content about COVID-19
- Gut microbiota and type 2 diabetes mellitus
- Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
- Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
- Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Publication History